Presently, over 160 innovative, software enabled systems are being used to efficiently manage and streamline various aspects of the complex supply chain of cell and advanced therapies

The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available / under development to mitigate the aforementioned concerns and simplify the management of biopharmaceutical supply chains.

 

To order this 510+ page report, which features 185+ figures and 400+ tables, please visit thishttps://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html

 

The USD 1.5 billion (by 2030) financial opportunity within the cell and advanced therapy supply chain management software solutions market has been analyzed across the following segments:

  • Application area
  • Sample collection and processing
  • Manufacturing
  • Logistics
  • Patient identification and treatment follow-up

 

  • Type of software solution
  • Cell orchestration platform
  • Enterprise manufacturing system
  • Inventory management system
  • Laboratory information management system
  • Logistics management system
  • Patient management system
  • Quality management system

 

  • Mode of Deployment
  • Cloud-based solution
  • On-premises solution

 

  • Scale of Operation
  • Clinical
  • Commercial

 

  • End user
  • Biobank
  • Cell therapy lab / commercial organization
  • Hospital / medical center
  • Research institute

 

  • Key geographical regions
  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

 

The Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions (Cell Orchestration Platforms, Enterprise Manufacturing Systems, Inventory Management Systems, Laboratory Information Management Systems, Logistics Management Systems, Patient Management Systems, Quality Management Systems, Tracking & Tracing Systems, and Other Software), 2019-2030 report features the following companies, which we identified to be key players in this domain:

  • Be The Match BioTherapies®
  • Brooks Life Sciences
  • Clarkston Consulting
  • Cryoport
  • Haemonetics
  • Hypertrust Patient Data Care
  • Lykan Bioscience
  • MAK-SYSTEM
  • MasterControl
  • SAP
  • SAVSU Technologies
  • sedApta Group
  • Stafa Cellular Therapy
  • Title21 Health Solutions
  • TraceLink
  • TrakCel
  • Vineti

 

Table of Contents

 

  1. Preface
  2. Executive Summary

 

  1. Introduction

 

  1. Current Market Landscape

 

  1. Company Competitiveness Analysis

 

  1. Cell and Advanced Therapies Supply Chain Management: Company Profiles

 

  1. Supply Chain Orchestration Platform: Emerging Trends and Key Players

 

  1. Funding and Investment Analysis

 

  1. Partnerships and Collaborations

 

  1. Supply Chain Utilization Use Cases

 

  1. Stakeholder Needs Analysis

 

  1. Cost Savings Analysis

 

  1. Market Forecast

 

  1. Executive Insights

 

  1. Concluding Remarks

 

  1. Appendix 1: List of Additional Supply Chain Management Software Solutions

 

  1. Appendix 2: Tabulated Data

 

  1. Appendix 3: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

(Visited 1 times, 1 visits today)

Comments

comments

You may also like...